跳至主要内容
临床试验/NCT02907502
NCT02907502已完成不适用

Effects of Milk Protein Intake in Young Children on Early Growth and Later Obesity Risk: a Multicentre Randomized Clinical Trial

Société des Produits Nestlé (SPN)3 个研究点 分布在 2 个国家目标入组 1,618 人开始时间: 2016年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
1,618
试验地点
3
主要终点
BMI-for-age z-score

研究概览

简要总结

To assess growth of children (enrolled between 11.5 and 13.5 months) fed with two iso-energetic, young-child formulas with different protein content during the second year of life

详细描述

This study is designed to investigate in a randomized double-blind parallel-group trial the growth and metabolic effects of different contributions of protein to total energy intakes in healthy children during the second year of life

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
11 Months 至 13 Months(Child)
性别
All
接受健康志愿者

入选标准

  • Having obtained his/her parents' (or his/her legally accepted representative [LAR's] written informed consent and having evidence of personally signed and dated informed consent document indicating that the child's parents/LAR have been informed of all pertinent aspects of the study
  • Child was born full term (≥ 37 weeks of gestation)
  • Age at enrollment: between 11.5 months and 13.5 months of age
  • 2.5 kg ≤ birth weight ≤ 4.5 kg
  • Born from a singleton pregnancy
  • Child's parent(s)/LAR is of legal age of consent, has sufficient local language skills to complete the informed consent and other study documents, is able to be contacted directly by telephone throughout the study, and is willing and able to fulfill the requirements of the study protocol.

排除标准

  • Diagnosed disorder considered to interfere with nutrition or growth (e.g. malabsorptive disorders as short bowel syndrome, inflammatory bowel disease; neurological and congenital disorders that may delay growth as cerebral palsy, agenesis of the corpus callosum, spina bifida, Down Syndrome, Cri Du Chat; disorders that may lead to obesity: Prader willi syndrome, Angelman syndrome, etc.)
  • Cows' milk allergy
  • Lactose intolerance
  • Participation in any other interventional clinical trial during the 4 weeks prior to enrollment
  • Infant who is being breastfed at the time of enrollment
  • Infant who does not usually drink 300ml of cow's and/or formula milk per day
  • Institutionalized children
  • Child or child's family who in the Investigator's judgment cannot be expected to comply with the protocol or study procedures

结局指标

主要结局

BMI-for-age z-score

时间窗: Age 24 months

WHO-growth standard

次要结局

  • BMI-for-age z-score(Age 72 months)
  • The percentage of overweight and obese children(Age 72 months)
  • Growth parameters: Anthropometry: Weight, Length, Heel knee length, Mid-arm circumference, Waist circumference, Hip circumference (only 48 months and 72 months), Head circumference, Triceps skinfold, Subscapular skinfold(Age 12, 18, 24, 48 and 72 months)
  • Child's development: Parental rating of child development with Ages & Stages Questionnaires®(Age 24 and 48 months)
  • Body composition: air displacement plethysmography(at 24, 48 and 72 months of age)
  • Metabolomic profile: Plasma and urine metabolic indicators of energy and protein metabolism (metabolomics with a focus on carnitines, amino acid catabolism, ketone bodies, Krebs cycle, and bacterial utilization of protein and carbohydrates)(Age 12, 18, 24, 48 and 72 months)
  • DNA methylation pattern: Methylation status of specific DNA regions (e.g. CpG sites)(Age 12, 24 and 72 months)
  • Blood pressure(Age 48 and 72 months)
  • Dietary intake: 24-hour recall(Age 12, 18, 24, 48 and 72 months)
  • Metabolic and endocrine markers: Blood and Urine markers(Age 12, 24 and 72 months)

研究者

发起方
Société des Produits Nestlé (SPN)
申办方类型
Industry
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验